Evidence map›Paper›PMID 26381405›Full record

ArticleThe Journal of biological chemistry2015

Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).

Brittany L Carpenter, Min Chen, Teresa Knifley, Kelley A Davis, Susan M W Harrison, Rachel L Stewart, Kathleen L O'Connor

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 31 citations in OpenAlex.

  1. Beyond DNA damage: 3D tumor models and the integrin mechanobiology of radioresistance.Journal of experimental & clinical cancer research : CR · 2026
    Review
  2. Review
  3. Article
  4. Amphiregulin in Fibrotic Diseases and Cancer.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Signatures of Dermal Fibroblasts from RDEB Pediatric Patients.International journal of molecular sciences · 2021
    Article
  9. Article
  10. Article
  11. The role of PDIA3 in myogenesis during muscle regeneration.Experimental & molecular medicine · 2020
    Article
  12. Article
  13. TMEM16A controls EGF-induced calcium signaling implicated in pancreatic cancer prognosis.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Integrins in the Spotlight of Cancer.International journal of molecular sciences · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Brittany L CarpenterMarkey Cancer Center, University of Kentucky, Lexington, Kentucky 40506-0509; Departments of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, Kentucky 40506-0509.
Min ChenMarkey Cancer Center, University of Kentucky, Lexington, Kentucky 40506-0509; Departments of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky 40506-0509.
Teresa KnifleyMarkey Cancer Center, University of Kentucky, Lexington, Kentucky 40506-0509.
Kelley A DavisMarkey Cancer Center, University of Kentucky, Lexington, Kentucky 40506-0509.
Susan M W HarrisonMarkey Cancer Center, University of Kentucky, Lexington, Kentucky 40506-0509.
Rachel L StewartMarkey Cancer Center, University of Kentucky, Lexington, Kentucky 40506-0509; Departments of Pathology and Laboratory Medicine, University of Kentucky, Lexington, Kentucky 40506-0509.
Kathleen L O'ConnorMarkey Cancer Center, University of Kentucky, Lexington, Kentucky 40506-0509; Departments of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, Kentucky 40506-0509. Electronic address: kloconnor@uky.edu.
Markey Cancer Center · USUniversity of Kentucky · US

Funding

Oncology Research Training for Surgeon-ScientistsT32CA160003 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers, Pamela Carmen Hull · 2011 to 2026
$3.2M
Interdisciplinary Research Training in Cancer BiologyT32CA165990 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers, KATHLEEN L. O'CONNOR · 2013 to 2026
$3.2M
Novel Mechanisms of Carcinoma Cell MigrationR01CA109136 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI O'CONNOR, KATHLEEN L. · 2006 to 2016
$2.6M
NCI NIH HHS R01 CA109136NCI NIH HHS T32 CA160003NCI NIH HHS T32 CA165990
6 · The paper itself

Abstract

Integrin α6β4 is up-regulated in pancreatic adenocarcinomas where it contributes to carcinoma cell invasion by altering the transcriptome. In this study, we found that integrin α6β4 up-regulates several genes in the epidermal growth factor receptor (EGFR) pathway, including amphiregulin (AREG), epiregulin (EREG), and ectodomain cleavage protease MMP1, which is mediated by promoter demethylation and NFAT5. The correlation of these genes with integrin α6β4 was confirmed in The Cancer Genome Atlas Pancreatic Cancer Database. Based on previous observations that integrin α6β4 cooperates with c-Met in pancreatic cancers, we examined the impact of EGFR signaling on hepatocyte growth factor (HGF)-stimulated migration and invasion. We found that AREG and EREG were required for autocrine EGFR signaling, as knocking down either ligand inhibited HGF-mediated migration and invasion. We further determined that HGF induced secretion of AREG, which is dependent on integrin-growth factor signaling pathways, including MAPK, PI3K, and PKC. Moreover, matrix metalloproteinase activity and integrin α6β4 signaling were required for AREG secretion. Blocking EGFR signaling with EGFR-specific antibodies or an EGFR tyrosine kinase inhibitor hindered HGF-stimulated pancreatic carcinoma cell chemotaxis and invasive growth in three-dimensional culture. Finally, we found that EGFR was phosphorylated in response to HGF stimulation that is dependent on EGFR kinase activity; however, c-Met phosphorylation in response to HGF was unaffected by EGFR signaling. Taken together, these data illustrate that integrin α6β4 stimulates invasion by promoting autocrine EGFR signaling through transcriptional up-regulation of key EGFR family members and by facilitating HGF-stimulated EGFR ligand secretion. These signaling events, in turn, promote pancreatic carcinoma migration and invasion.

Indexed as

AmphiregulinCell Line, TumorCell MovementEGF Family of ProteinsEpiregulinErbB ReceptorsGene Knockdown TechniquesHepatocyte Growth FactorHumansIntegrin alpha6beta4Matrix Metalloproteinase 1Models, BiologicalNeoplasm InvasivenessPancreatic NeoplasmsRNA, MessengerRNA, NeoplasmAmphiregulinAREG protein, humanEGF Family of ProteinsEGFR protein, humanEpiregulinErbB ReceptorsEREG protein, humanHepatocyte Growth FactorHGF protein, humanIntegrin alpha6beta4Matrix Metalloproteinase 1MMP1 protein, humanRNA, MessengerRNA, Neoplasmpancreatic cancerprotein secretionreceptor protein-tyrosine kinasereceptor protein-tyrosine kinasesreceptor regulationreceptor tyrosine kinasesignal transduction

Identifiers

PMID26381405
PMCPMC4646402
OpenAlexW2271723211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.